{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:53:39Z","timestamp":1780372419516,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.maturitas.2025.108623","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:11:01Z","timestamp":1748430661000},"page":"108623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Female sexual dysfunction as an adverse effect of drugs: a narrative review"],"prefix":"10.1016","volume":"199","author":[{"given":"Mikael O.W.","family":"Piha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksi","family":"Tornio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2025.108623_bb0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJMcp2313307","article-title":"Sexual dysfunction in women","volume":"391","author":"Davis","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0010","series-title":"The textbook of clinical sexual medicine","first-page":"39","article-title":"The human sexual response cycle","author":"Levin","year":"2017"},{"key":"10.1016\/j.maturitas.2025.108623_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/sxmrev\/qead058","article-title":"The problem of calculating the prevalence of sexual dysfunction: a meta-analysis attending gender","volume":"12","author":"Ram\u00edrez-Santos","year":"2024","journal-title":"Sex. Med. Rev."},{"key":"10.1016\/j.maturitas.2025.108623_bb0020","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2019.09.027","article-title":"The prevalence of sexual dysfunctions and sexually related distress in young women: a cross-sectional survey","volume":"113","author":"Zheng","year":"2020","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2025.108623_bb0030","article-title":"Women\u2019s sexual dysfunction associated with psychiatric disorders and their treatment","volume":"14","author":"Basson","year":"2018","journal-title":"Womens Health (Lond.)"},{"key":"10.1016\/j.maturitas.2025.108623_bb0035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jsxm.2019.06.004","article-title":"Medication use and sexual function: a population-based study in middle aged women","volume":"16","author":"Gueldini de Moraes","year":"2019","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40264-022-01174-3","article-title":"Drug-induced sexual dysfunction: an analysis of reports to a National Pharmacovigilance Database","volume":"45","author":"Valeiro","year":"2022","journal-title":"Drug Saf."},{"key":"10.1016\/j.maturitas.2025.108623_bb0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/09638237.2019.1581333","article-title":"Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication","volume":"29","author":"Souaiby","year":"2020","journal-title":"J. Ment. Health"},{"key":"10.1016\/j.maturitas.2025.108623_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1345205","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.maturitas.2025.108623_bb0055","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10508-018-1365-6","article-title":"A real-world study on antidepressant-associated sexual dysfunction in 2144 outpatients: the SALSEX I study","volume":"48","author":"Montejo","year":"2019","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.maturitas.2025.108623_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis","volume":"29","author":"Serretti","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1017\/S1092852915000553","article-title":"Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis","volume":"21","author":"Jacobsen","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.maturitas.2025.108623_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0075","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.mayocp.2016.04.033","article-title":"Antidepressant-induced female sexual dysfunction","volume":"91","author":"Lorenz","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.maturitas.2025.108623_bb0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.5653","article-title":"Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: a systematic review","volume":"32","author":"Tarchi","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.maturitas.2025.108623_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0033-1347177","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.maturitas.2025.108623_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.maturitas.2025.108623_bb0100","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/clinem\/dgz022","article-title":"Opioids and their endocrine effects: a systematic review and meta-analysis","volume":"105","author":"de Vries","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2025.108623_bb0105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jsxm.2016.07.003","article-title":"Opioids increase sexual dysfunction in patients with non-cancer pain","volume":"13","author":"Ajo","year":"2016","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0110","article-title":"Gender difference in long-term use of opioids among Taiwan officially registered patients with chronic noncancer pain","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.maturitas.2025.108623_bb0115","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/pm\/pny122","article-title":"Chronic pain, opioid therapy, sexual desire, and satisfaction in sexual life: a population-based survey","volume":"20","author":"Birke","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsxm.2021.11.018","article-title":"A scoping review of the prevalence and correlates of sexual dysfunction in adults with substance use disorders","volume":"19","author":"Ghosh","year":"2022","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107823","article-title":"The effect of methadone on the hypothalamic pituitary gonadal axis and sexual function: a systematic review","volume":"207","author":"Ortman","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.maturitas.2025.108623_bb0130","author":"Corporation"},{"key":"10.1016\/j.maturitas.2025.108623_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sxmrev\/qeae011","article-title":"Combined estrogen-progestin oral contraceptives and female sexuality: an updated review","volume":"12","author":"Krapf","year":"2024","journal-title":"Sex. Med. Rev."},{"key":"10.1016\/j.maturitas.2025.108623_bb0140","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.jsxm.2020.06.008","article-title":"Is there an association between contraception and sexual dysfunction in women? A systematic review and meta-analysis based on female sexual function index","volume":"17","author":"Huang","year":"2020","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jsxm.2019.04.007","article-title":"Systematic review and meta-analysis for sexual dysfunction in women with hypertension","volume":"16","author":"Choy","year":"2019","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.urolonc.2021.01.017","article-title":"Biology of iatrogenic sexual dysfunction in men and women survivors of cancer","volume":"40","author":"Priviero","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0155","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.3390\/jcm11226723","article-title":"Sexual health after a breast cancer diagnosis: addressing a forgotten aspect of survivorship","volume":"11","author":"Vegunta","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0160","article-title":"Care for breast cancer survivors in Asian countries: a review of sexual dysfunction","volume":"20","author":"Jehan","year":"2024","journal-title":"Womens Health (Lond.)"},{"key":"10.1016\/j.maturitas.2025.108623_bb0165","first-page":"160","article-title":"Breast cancer and sexual function","volume":"4","author":"Boswell","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103754","article-title":"Managing sexual health challenges in breast cancer survivors: a comprehensive review","volume":"76","author":"Cucciniello","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.maturitas.2025.108623_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1256548","article-title":"Comparative safety of different recommended doses of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials [supplementary material]","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.maturitas.2025.108623_bb0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1060028020951928","article-title":"Prevention and management of genital mycotic infections in the setting of sodium-glucose cotransporter 2 inhibitors","volume":"55","author":"Engelhardt","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.maturitas.2025.108623_bb0185","first-page":"62","article-title":"Benzodiazepines related sexual dysfunctions: a critical review on pharmacology and mechanism of action","volume":"19","author":"Hosseinzadeh Zoroufchi","year":"2021","journal-title":"Rev. Int. Androl."},{"key":"10.1016\/j.maturitas.2025.108623_bb0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hup.2457","article-title":"Lithium and sexual dysfunction: an under-researched area","volume":"30","author":"Elnazer","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.maturitas.2025.108623_bb0195","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jsxm.2020.01.032","article-title":"Sexual dysfunction and mood stabilizers in long-term stable patients with bipolar disorder","volume":"17","author":"Garc\u00eda-Blanco","year":"2020","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2025.108623_bb0200","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.2174\/1381612823666171004115230","article-title":"Sexual dysfunction in epilepsy and the role of anti-epileptic drugs","volume":"23","author":"Yogarajah","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.maturitas.2025.108623_bb0205","article-title":"Sexual disorders and quality of life in Parkinson\u2019s disease","volume":"9","author":"Malcher","year":"2021","journal-title":"Sex. Med."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512225004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512225004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T14:44:03Z","timestamp":1754318643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512225004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0378512225004311"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2025.108623","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female sexual dysfunction as an adverse effect of drugs: a narrative review","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2025.108623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108623"}}